Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer COVID-19 Vaccine Trial Diversity Slips As Enrollment Rises, Unlike Moderna

Executive Summary

Trial diversity is among the issues that stakeholders worry could hinder vaccine uptake.

You may also be interested in...



Sponsors Want Answers On Consequences Of Missing US FDA Trial Diversity Goals

No negative actions have been taken in the US FDA’s oncology review divisions, but vague diversity guidance continues to raise concerns.

Clinical Trial Diversity Campaign Distracting From Health Equity Problems, Califf Says

The FDA commissioner says that improving health disparities would fix the lack of diversity in clinical trials.

OCE ‘Project’ To Help Understand Trial Site Selection, Also May Inform Policy

Project Site Selector will allow FDA Oncology Center of Excellence staff to discuss site selection process with industry and potentially help improve clinical trial diversity efforts.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS142923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel